{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:58:59Z","timestamp":1790499539737,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006263","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000}}],"reference-count":83,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006263.pub2","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T12:14:50Z","timestamp":1233663290000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Interventions for pemphigus vulgaris and pemphigus foliaceus"],"prefix":"10.1002","volume":"2010","author":[{"given":"Linda K","family":"Martin","sequence":"first","affiliation":[{"name":"St George Hospital; Department of Dermatology ; Gray St Kogarah Sydney NSW Australia 2217"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Liza","family":"Agero","sequence":"additional","affiliation":[{"name":"St George Hospital; Department of Dermatology; Gray St Kogarah Sydney NSW Australia 2043"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Werth","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania; Department of Dermatology; 2 Rhoads 3400 Spruce Street Philadelphia Pennsylvania USA PA 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Monash University; Department of Rural and Indigenous Health; PO Box 973 3 Ollerton Avenue Melbourne Victoria Australia 3825"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Segall","sequence":"additional","affiliation":[{"name":"International Pemphigus & Pemphigoid Foundation; 2701 Cottage Way #16 Sacramento California USA 95825"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedee F","family":"Murrell","sequence":"additional","affiliation":[{"name":"St George Hospital & University of New South Wales; Department of Dermatology; Belgrave St Kogarah Sydney NSW Australia 2217"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"10.1002\/14651858.CD006263.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0002|cit2","first-page":"622","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-4362.1994.tb01003.x","article-title":"Treatment of oral pemphigus vulgaris","volume":"33","author":"Chrysomallis","year":"1994","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0006|cit6","first-page":"38","article-title":"The clinical and laboratory research for Chinese traditional medicine in the treatment of pemphigus (Chinese)","volume":"32","author":"Luo","year":"2003","journal-title":"Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0007|cit7","first-page":"570","article-title":"Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial","volume":"143","author":"Mentink","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD006263.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-4362.1990.tb04765.x","article-title":"Pemphigus therapy with oral prednisolone regimens. A 5-year study","volume":"29","author":"Ratnam","year":"1990","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study","volume":"3","author":"Rose","year":"2005","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-3083.2006.01873.x","article-title":"Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial","volume":"21","author":"Tabrizi","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomised placebo-controlled clinical trial of dapsone as a Glucocorticoid-sparing agent in maintenance phase Pemphigus Vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0012|cit12","first-page":"300","article-title":"Treatment of pemphigus: a local experience","volume":"48","author":"Akhtar","year":"1998","journal-title":"Journal of the Pakistan Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD006263.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-4362.1970.tb04592.x","article-title":"The treatment of Brazilian Pemphigus Foliaceus (Fogo selvagem)","volume":"9","author":"Auad","year":"1970","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD006263.pub2-BIB0014|cit14","first-page":"131","article-title":"Coadjuvant therapy for the treatment of South American pemphigus foliaceus with auraofin, A double-blind study","volume":"61","author":"Auad","year":"1986","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"7","key":"10.1002\/14651858.CD006263.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/08916930600972016","article-title":"IVIG selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris","volume":"39","author":"Bystryn","year":"2006","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1002\/14651858.CD006263.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-4362.1999.00624.x","article-title":"Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients","volume":"38","author":"Calebotta","year":"1999","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-3083.2007.02286.x","article-title":"An alternate-day corticosteroid regimen for pemphigus vularis. A 13-year prospective study","volume":"21","author":"Chaidemenos","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"2","key":"10.1002\/14651858.CD006263.pub2-BIB0018|cit18","first-page":"111","article-title":"Dapsone as a second glucocorticoid-sparing agent in addition to azathioprine in treatment of pemphigus vulgaris","volume":"10","author":"Chams Davatchi","year":"2007","journal-title":"Iranian Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of Severe Pemphigus with Rituximab","volume":"143","author":"Cianchini","year":"2007","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD006263.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaad.2008.01.007","article-title":"Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus","volume":"58","author":"Czernick","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0021|cit21","first-page":"212","article-title":"The effect of combined treatment with prednisone and cyclosporine in pemphigus vulgaris. A comparative open study. Abstract","volume":"100","author":"David","year":"1993","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD006263.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-4632.2008.03423.x","article-title":"Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris","volume":"47","author":"Faurschou","year":"2008","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1468-3083.2002.00461.x","article-title":"Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols","volume":"16","author":"Femiano","year":"2002","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0036-46652001000100007","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20 year period","volume":"43","author":"Fernandes","year":"2001","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2007.07800.x","article-title":"Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients","volume":"156","author":"Goh","year":"2007","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-4632.2006.02766.x","article-title":"Healing effect of Pilocarpine gel 4% on skin lesions of pemphigus vulgaris","volume":"45","author":"Iraji","year":"2006","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1468-3083.2006.02074.x","article-title":"Gold: an old drug still working in refractory pemphigus","volume":"21","author":"Iranzo","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD006263.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD006263.pub2-BIB0030|cit30","first-page":"715","article-title":"Evidence-based treatment for a patient with oral pemphigus (Chinese)","volume":"5","author":"Li","year":"2005","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006263.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0030-4220(94)90318-2","article-title":"Double-blind clinical trial of 0.05% clobetasol propionate ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases","volume":"77","author":"Lozada-Nur","year":"1994","journal-title":"Oral surgery, oral medicine, and oral pathology"},{"issue":"4","key":"10.1002\/14651858.CD006263.pub2-BIB0032|cit32","first-page":"335","article-title":"Rituximab therapy in severe juvenile pemphigus vulgaris","volume":"80","author":"Mamelak","year":"2007","journal-title":"Cutis"},{"issue":"11","key":"10.1002\/14651858.CD006263.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00105-007-1414-x","article-title":"Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins","volume":"58","author":"Muhlhoff","year":"2007","journal-title":"Hautarzt"},{"issue":"3","key":"10.1002\/14651858.CD006263.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0378-6323.41366","article-title":"Current regimen of pulse therapy for pemphigus: minor modifications, improved results","volume":"74","author":"Pasricha","year":"2008","journal-title":"Indian Journal of Dermatology, Venerology & Leprology"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0035|cit35","first-page":"1","article-title":"Pulse versus oral Methylprednisolone Therapy in Pemphigus Vulgaris","volume":"10","author":"Shahidi-Dadras","year":"2007","journal-title":"Archives of Iranian Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0190-9622(90)70004-2","article-title":"Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies","volume":"22","author":"Tan-Lim","year":"1990","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1999.03071.x","article-title":"Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulines","volume":"141","author":"Toth","year":"1999","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Hashimoto K Amagai M Ikegda S A double-blind clinical trial of IVIG for pemphigus in Japan Post-IID 2008 International Meeting on Autoimmune Bullous Diseases (abstracts online) 2008 38","DOI":"10.1038\/jid.2008.199"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0039|cit39","unstructured":"Schmidt E Shimanovich I Nitschke M Rose C Grabbe J Zillikens D Treatment of severe pemphigus with the combination of Protein A Immunoadsorption and Rituximab Post-IID 2008 International Meeting on Autoimmune Bullous Diseases (abstracts online) 2008 56"},{"issue":"5","key":"10.1002\/14651858.CD006263.pub2-BIB0040|cit40","first-page":"150","article-title":"Comparison of steroid-sparing combinations for the treatment of pemphigus vulgaris","volume":"34","author":"Meyer","year":"2008","journal-title":"Aktuelle Dermatologie"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0041|cit41","first-page":"A5","article-title":"An open-label phase I clinical study to assess the safety of PI-0924 in patients with pemphigus (abstract)","volume":"125","author":"Werth","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0042|cit42","unstructured":"Use of Prednisone with placebo or azathioprine in pemphigus vulgaris Ongoing study April 2008"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0043|cit43","unstructured":"Effect of Topical Cortiocosteroids on Epidermal Adhesion Strength in Pemphigus Vulgaris Ongoing study"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0044|cit44","unstructured":"Phase II study of high-dose cyclophosphamide in participants with refractory pemphigus Ongoing study April 1999"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0045|cit45","unstructured":"Study of Etanercept (Enbel) in the Treatment of Pemphigus Vulgaris Ongoing study June 2004"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0046|cit46","unstructured":"Use of Infliximab for the Treatment of Pemphigus Vulgaris Ongoing study March 2006"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0047|cit47","unstructured":"Randomised trial of IVIG with or without cyclophosphamide in Pemphigus Ongoing study April 2007"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0048|cit48","unstructured":"The use of KC706 for the Treatment of Pemphigus Vulgaris Ongoing study November 2007"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0049|cit49","unstructured":"A study to assess the effect of Cellcept (mycophenolate mofetil) and reduced corticosteroids in partients with active pemphigus vulgaris Ongoing study May 2004"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0050|cit50","unstructured":"Hematopoietic Stem Cell Support in Patients with Autoimmune Bullous Skin Disorders Ongoing study October 2002"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323(25)","author":"Anhalt","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0053|cit53","first-page":"224","article-title":"Anti-B- cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus--an update","volume":"15","author":"Arin","year":"2005","journal-title":"European Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0054|cit54","first-page":"41.5","volume-title":"Rook's Textbook of Dermatology","volume":"2","author":"Wojnarowska","year":"2004"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy of pemphigus","volume":"120(7)","author":"Bystryn","year":"1984","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","article-title":"Pemphigus: analysis of 1209 cases","volume":"44","author":"Chams-Davatchi","year":"2005","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding","year":"1997","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/mjd.2000.108366","article-title":"Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris","volume":"43","author":"Engineer","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archderm.1980.01640270045011","article-title":"The correlation of disease activity and antibody titers in pemphigus","volume":"116","author":"Fitzpatrick","year":"1980","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1440-0960.2001.00509.x","article-title":"Comparative study of pemphigus vulgaris and pemphigus foliaceus in Singapore","volume":"42","author":"Goon","year":"2001","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD006263.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI28547","article-title":"T cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD006263.pub2-BIB0065|cit65","article-title":"Grey literature in meta-analyses of randomized trials of health care interventions","author":"Hopewell","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1067\/mjd.2003.438","article-title":"Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris","volume":"48","author":"Jamora","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2230.2001.00779.x","article-title":"A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders","volume":"26","author":"Jolles","year":"2001","journal-title":"Clinical and Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archdermatol.2007.14","article-title":"Treatment of Pemphigus: The Need for More Evidence","volume":"144","author":"Martin","year":"2008","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","article-title":"Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris","volume":"49","author":"Mimouni","year":"2003","journal-title":"Journal of the American Academy of Der matology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1995.tb02497.x","article-title":"The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period","volume":"133","author":"Mourellou","year":"1995","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD006263.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus Statement on Definitions of Disease Endpoints and Therapeutic Response for Pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38(3)","author":"Pisanti","year":"1974","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-4632.2004.01739.x","article-title":"The profile of fogo selvagem (endemic pemphigus foliaceus) at the University Hospital of BrasiliaBrazil. Epidemiological and clinical considerations","volume":"44","author":"Quinteiro Ribeiro","year":"2005","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD006263.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01706318","article-title":"Plasmapheresis: Techniques and complications","volume":"16","author":"Reimann","year":"1990","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus: a 20-year review of 107 patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-4362.2001.01099.x","article-title":"Pemphigus and diet: does a link exist?","volume":"40","author":"Ruocco","year":"2001","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2005.03.005","article-title":"Role of intramolecular epitope spreading in pemphigus vulgaris","volume":"116","author":"Salato","year":"2005","journal-title":"Clinical Immunology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2249.2001.01637.x","article-title":"Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses","volume":"125","author":"Sami","year":"2001","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1468-3083.2002.00413.x","article-title":"Dexamethasone pulse therapy in pemphigus","volume":"16","author":"Toth","year":"2002","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaut.2005.03.006","article-title":"Genetic factors in pemphigus","volume":"24","author":"Tron","year":"2005","journal-title":"Journal of Autoimmunity"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mjd.2000.109297","article-title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","volume":"43","author":"Turner","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD006263.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD006263.pub2-BIB0083|cit83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus (Protocol)","author":"Martin","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006263.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:01:50Z","timestamp":1782086510000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006263.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006263.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}